191 related articles for article (PubMed ID: 22074588)
21. Systemic treatment of malignant melanoma: grade is as important as stage.
Retsas S
Clin Exp Dermatol; 1997 Mar; 22(2):67-71. PubMed ID: 9330068
[TBL] [Abstract][Full Text] [Related]
22. Side effects and toxicities of targeted therapies in stage IV melanoma.
Ascierto PA; Bastholt L; Hersey P; Cinat G; Eggermont AM; Hauschild A; Espinosa E; Robert C
Am J Ther; 2015; 22(1):44-53. PubMed ID: 24185314
[TBL] [Abstract][Full Text] [Related]
23. Immunological strategies to fight skin cancer.
Berman B; Perez OA; Zell D
Skin Therapy Lett; 2006 Jun; 11(5):1-7. PubMed ID: 16820869
[TBL] [Abstract][Full Text] [Related]
24. Novel treatment strategies for malignant melanoma: a new beginning?
Kasper B; D'Hondt V; Vereecken P; Awada A
Crit Rev Oncol Hematol; 2007 Apr; 62(1):16-22. PubMed ID: 17208006
[TBL] [Abstract][Full Text] [Related]
25. Demodex as a Delivery Vector for Topical Targeted Medications in the Skin for Early Melanoma and Non-Melanoma Skin Cancer.
Strobel SL
Ann Clin Lab Sci; 2017 Sep; 47(5):604-605. PubMed ID: 29066489
[TBL] [Abstract][Full Text] [Related]
26. Reactivation of p53 as therapeutic intervention for malignant melanoma.
Jochemsen AG
Curr Opin Oncol; 2014 Jan; 26(1):114-9. PubMed ID: 24275854
[TBL] [Abstract][Full Text] [Related]
27. Immune checkpoint inhibitors in melanoma provide the cornerstones for curative therapies.
Eggermont AM; Maio M; Robert C
Semin Oncol; 2015 Jun; 42(3):429-35. PubMed ID: 25965361
[TBL] [Abstract][Full Text] [Related]
28. Nanotechnology-empowered strategies in treatment of skin cancer.
Chandra J; Hasan N; Nasir N; Wahab S; Thanikachalam PV; Sahebkar A; Ahmad FJ; Kesharwani P
Environ Res; 2023 Oct; 235():116649. PubMed ID: 37451568
[TBL] [Abstract][Full Text] [Related]
29. The treatment of metastatic melanoma with chemotherapy and biologics.
Atkins MB
Curr Opin Oncol; 1997 Mar; 9(2):205-13. PubMed ID: 9161801
[TBL] [Abstract][Full Text] [Related]
30. The ipilimumab lesson in melanoma: achieving long-term survival.
Delyon J; Maio M; Lebbé C
Semin Oncol; 2015 Jun; 42(3):387-401. PubMed ID: 25965357
[TBL] [Abstract][Full Text] [Related]
31. Molecularly targeted therapy for melanoma: current reality and future options.
Becker JC; Kirkwood JM; Agarwala SS; Dummer R; Schrama D; Hauschild A
Cancer; 2006 Nov; 107(10):2317-27. PubMed ID: 17039502
[TBL] [Abstract][Full Text] [Related]
32. Targeting Histone Deacetylases in Malignant Melanoma: A Future Therapeutic Agent or Just Great Expectations?
Garmpis N; Damaskos C; Garmpi A; Dimitroulis D; Spartalis E; Margonis GA; Schizas D; Deskou I; Doula C; Magkouti E; Andreatos N; Antoniou EA; Nonni A; Kontzoglou K; Mantas D
Anticancer Res; 2017 Oct; 37(10):5355-5362. PubMed ID: 28982843
[TBL] [Abstract][Full Text] [Related]
33. Treatment algorithms in stage IV melanoma.
Espinosa E; Grob JJ; Dummer R; Rutkowski P; Robert C; Gogas H; Kefford R; Eggermont AM; Martin Algarra S; Hauschild A; Schadendorf D
Am J Ther; 2015; 22(1):61-7. PubMed ID: 24413374
[TBL] [Abstract][Full Text] [Related]
34. Chemotherapy and chemoimmunotherapy for metastatic malignant melanoma: review and recent advances.
Khayat D; Coeffic D
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():238-47. PubMed ID: 10895160
[No Abstract] [Full Text] [Related]
35. Pharmacotherapy of metastatic melanoma: emerging trends and opportunities for a cure.
Pretto F; Neri D
Pharmacol Ther; 2013 Sep; 139(3):405-11. PubMed ID: 23711792
[TBL] [Abstract][Full Text] [Related]
36. Recent developments in nanomedicine for melanoma treatment.
Tang JQ; Hou XY; Yang CS; Li YX; Xin Y; Guo WW; Wei ZP; Liu YQ; Jiang G
Int J Cancer; 2017 Aug; 141(4):646-653. PubMed ID: 28340496
[TBL] [Abstract][Full Text] [Related]
37. Adjuvant ipilimumab in stage III melanoma: New landscape, new questions.
Eggermont AM
Eur J Cancer; 2016 Dec; 69():39-42. PubMed ID: 27816830
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic potential of marine peptides in malignant melanoma.
Ahmed S; Alam W; Alsharif KF; Aschner M; Alzahrani FM; Saso L; Khan H
Environ Res; 2023 Jun; 227():115771. PubMed ID: 36967001
[TBL] [Abstract][Full Text] [Related]
39. New drugs in melanoma: it's a whole new world.
Eggermont AM; Robert C
Eur J Cancer; 2011 Sep; 47(14):2150-7. PubMed ID: 21802280
[TBL] [Abstract][Full Text] [Related]
40. American Academy of Dermatology-68th annual meeting. 5-9 March 2010, Miami Beach, FL, USA.
Whang T; Goldenberg G
IDrugs; 2010 May; 13(5):311-3. PubMed ID: 20432186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
